EXCELLGENE
Excellgene partners with Bharat Biotech for variant proof Covid vaccineThe Coalition for Epidemic Preparedness Innovations has funded the partnership and will "provide up to USD 19.3 million in funding to devel...
CEPI partners Bharat Biotech to develop 'variant-proof' vaccine"Our expertise in product development and innovation, especially with novel adjuvants and platform technologies will add to the strong part...
- Load More